– USA, OH – Enable Injections, Inc., a company developing and manufacturing the enFuse platform of wearable drug delivery systems, today announced the appointment of Vickie Capps to its Board of Directors.
Vickie Capps will also join the audit committee as head.
About Vickie Capps
Vickie Capps has had a distinguished career in finance and executive leadership with extensive board experience. In addition to Enable, she currently serves on the boards of other healthcare and life sciences companies, including Amedisys, Inc. and Janux Therapeutics, Inc., as well as several other past board positions. She is also a member of the Senior Advisory Board of Consonance Capital Partners, a healthcare-focused private equity firm. Vickie previously served as chief financial officer of DJO Global, Inc. from 2002-2013. She is a Certified Public Accountant, and she received her B.S. in business administration and accounting from San Diego State University.
“The enFuse technology could make a significant impact on the drug delivery industry and how patients receive life-altering medication,” said Vickie Capps. “I’m excited to be part of this innovative company and I look forward to working with the team on increasingly meaningful milestones in the future.”
About Enable Injections
Cincinnati-based Enable Injections is a global healthcare innovation company developing and manufacturing drug delivery systems designed to improve the patient experience. Enable’s body-worn enFuse delivers high-volume pharmaceutical and biologic therapeutics via subcutaneous administration, to improve convenience, support superior outcomes, and advance healthcare system economics.
For more information: https://enableinjections.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
